Clinical Trial Update: Impact of Photobiomodulation (PBM) on Biomarkers of Alzheimer's Disease [NA]

View source ↗

Summary

A completed clinical trial investigating the impact of Photobiomodulation on biomarkers of Alzheimer’s disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Snippet

Sponsor: University of California, San Francisco | Conditions: Alzheimer Disease | NA | Status: COMPLETED | Results posted: 2022-07-01